Filgrastim is marketed under several brand names, including Neupogen (Amgen), Imumax (Abbott Laboratories), Grafeel (Dr. Reddy's Laboratories), Neukine (Intas Biopharmaceuticals), Emgrast (Emcure Pharmaceuticals), Religrast (Reliance Life Sciences), Zarzio (Sandoz), Nufil (Biocon) and others.
Erythropoietin injection, under the brand name of Erykine, for anemia due to critical illness like chemotherapy, was introduced in Aug 2005 and Interferon α2b, under the brand name of Intalfa, was launched in April 2007.